John Ferrazza,MBA’s Post

Homologous recombination deficiency (HRD) testing helps guide personalized PARP inhibitor therapy for patients living with ovarian cancer. Tune in to Labcorp Perspectives to hear from Dr. Rebecca Previs and Dr. Alison Roos on how expanded HRD testing can transform precision medicine and improve outcomes for ovarian cancer patients. Check out the latest episode to learn more about the future of precision medicine: #PrecisionOncology#PersonalizedMedicine #CancerResearch #GynOnc

Homologous recombination deficiency (HRD) testing helps guide personalized PARP inhibitor therapy for patients living with ovarian cancer. Tune in to Labcorp Perspectives to hear from Dr. Rebecca Previs and Dr. Alison Roos on how expanded HRD testing can transform precision medicine and improve outcomes for ovarian cancer patients. Check out the latest episode to learn more about the future of precision medicine: http://spr.ly/6046YlAVe #PrecisionOncology #PersonalizedMedicine #CancerResearch #GynOnc

Dealing with bladder cancer can be a difficult journey, which is why we are committed to holding discussions about advanced precision therapies and personalised patient care. Our upcoming webinar is a unique opportunity to gain valuable knowledge and understand the innovative approach to bladder cancer treatments. Highly recommend registering for the webinar to learn more about this important topic! https://lnkd.in/d63CDhnt

Balancing Clinical and Economic Factors in Early Breast Cancer Treatment: The panelists discuss the clinical and economic factors that influence treatment decisions for early breast cancer (eBC), as well as the differences between eBC and metastatic breast cancer (mBC) in terms of adverse event management protocols and strategies for optimizing patient adherence. #finance #pharmacy #lifesciences

🧬 Understand a Type of Cancer Each Week: Prostate Cancer 🎗️ Prostate cancer is one of the most common cancers in men. Knowing the signs, risk factors, and myths surrounding prostate cancer can help in its early detection and treatment.   Let’s take a closer look at this important topic 👇 #ProstateCancer #CancerAwareness #CancerPrevention #CancerResearch

On World Pancreatic Cancer Day, early detection is crucial in cancer diagnosis, especially with pancreatic cancer. Recognizing the warning signs increases the chances of catching the disease early, which can significantly improve outcomes. To continue reading, visit: https://bit.ly/4ed2eVP

Recent FDA approvals have resulted in some exciting changes that are bringing #TargetedTherapy into the first-line setting for hormone receptor-positive, HER2-negative recurrent, metastatic #BreastCancer. Join us for a new Foundation Frontiers discussion where I take a deep dive into the new treatment options available for patients with advanced breast cancer and explore the role #ComprehensiveGenomicProfiling can play in guiding decision-making for HR+/HER2- breast cancer.  Watch here: https://lnkd.in/gxiqar5P

Experts discuss the necessity of ESR1 mutation testing when considering treatment with elacestrant in patients with ER+/HER2– metastatic breast cancer and discuss unmet needs in this patient population. They also describe options for mutation and resistance marker testing to guide treatment selection in this #PeerExchange series. Watch here: https://bit.ly/3WdkGsj #ManagedCare #BreastCancer

In this webinar, we discuss the importance of biomarker testing for therapeutic implications in metastatic breast cancer. Register to hear patient cases where #biomarker testing contributed to tailored treatment strategies in the setting of metastatic breast cancer: #MetastaticBreastCancer

This growing field of #CardioOncology is focused not just on how #cancertreatments can cause #cardiotoxicity but is mainly centred around keeping hearts safe during cancer treatment so that #canceroutcomes are improved and that #cancersurvivorship is optimised. One in two of us will develop cancer at some point - hence investment in research is critical to be able to fully understand these complex issues. Honoured to have been able to contribute to this JACC Journals manuscript. #Oncology #CardioEd #cancer #prostatecancer #breastcancer #colorectalcancer